ARCHIVES

Pharmacia Says SU5416 Doesn’t Benefit Colorectal Cancer Patients, Closes Trial.

This article is from The Cancer Letter archive.

Vol. 28 No. 09 | March 1, 2002

Download PDF Visit The Full Archive

Related Articles

UT System Launches Probe of Submission Of Controversial MD Anderson Grant

June 8, 2012

AACI, SCO, ACCC Hold Meeting With HCFA On DRG Issue

June 17, 1983

How NCI Would Apportion New Round Of budget Cuts- 1980 $17 Million, 1981 $42.7 Million

April 11, 1980

Partnership Points to New Path Forward For Drug Approval and Clinical Research

June 20, 2014

Austria Has highest Cancer Rate, Little NCI Support

June 17, 1977

High-Dose Vitamin D With Docetaxel In Testing For Advanced Prostate Cancer

September 27, 2002